Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

The following is information provided by Pfizer and BioNTech.On March 13, 2020, Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to collaboration to combat COVID-19.  Pfizer Inc. and BioNTech announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) […]

IXINITY Statement on Product Availability

The following is information provided by IXINITY. Read the full statement here. “The health and safety of individuals who rely on our products, their caregivers and community members, healthcare professionals, and our own team is of upmost importance to Medexus Pharma, the company behind IXINITY.  We want to reassure the community that we currently do […]

Plasma Protein Therapeutics Association Updated Statement Regarding Coronavirus

The following is a statement provided by PPTA. “Hello Stakeholders, As previously noted, I am writing to inform you of an update to PPTA’s statement regarding coronavirus and the safety of plasma protein therapies. This update provides clarity regarding the safety margins of plasma protein therapies manufactured by PPTA member companies and maintains the main assessment of […]